$1.200
-0.010 (-0.83%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による SPRO の予測・予想
Alphio's SPRO stock price prediction model matches the current Spero Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.19 (-0.42%). The 1-week path is $1.19 (-0.44%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Spero Therapeutics Inc 株は買うべき?
Spero Therapeutics Inc is not a strong buy at this moment. The current price is $1.20, and the RSI indicates a bearish trend at 38.53, suggesting the stock is oversold. While the company has secured a significant licensing deal worth up to $1.1 billion, its recent earnings report showed zero revenue for Q2 2026 and a net loss of $9.6 million, which raises concerns about its financial stability. The stock has experienced a year-to-date change of -48.94%, indicating substantial declines, and the forward P/E ratio is currently at 0, reflecting uncertainty in future earnings. The main risk is the lack of revenue generation, as evidenced by the zero revenue reported for Q2 2026.
SPRO の株価は Friday に $1.20 で引け、その前に下落 -0.83%
Spero Therapeutics Inc (SPRO) last closed at $1.2, losing -0.83%. These facts feed the 1-day and 1-week SPRO price prediction above.
アナリストのコンセンサス
Spero Therapeutics Inc(SPRO):買い 3、中立 1、売り 0。見通し:Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
予想の要因
Spero Therapeutics Inc(SPRO)の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが SPRO に最も近い銘柄を、類似度順に表示します。
SPRO の季節性分析
Historically the probability of a positive August return for SPRO is 33.33%. May offers the highest probability of a positive month at 58.73%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。